once-weekly semaglutide in adults with overweight or obesity Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss early trials. The potential benefit European Commission Approves 7.2 mg

In skincare, they act as signalling molecules, communicating with skin cells and encouraging processes such as collagen production, repair and hydration

Heres the simple truth: once a year, around this season, we run a special Reader Event to thank our audience and make our most popular collections easier to access

Tirzepatide follows the same pattern: Mounjaro: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg for type 2 diabetes Zepbound: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg for obesity The doses are identical

These include high blood pressure, heart conditions, and atherosclerosisa disease where plaque builds up inside your arteries

Are these compounded drugs attractive for their easy access and starkly reduced prices (think $200 a month compared with $1,000-plus) safe

[8], p